Terms: = Leukemia AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12
113 results:
1. The Eμ-ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia.
Farrokhi A; Atre T; Rever J; Fidanza M; Duey W; Salitra S; Myung J; Guo M; Jo S; Uzozie A; Baharvand F; Rolf N; Auer F; Hauer J; Grupp SA; Eydoux P; Lange PF; Seif AE; Maxwell CA; Reid GSD
Leukemia; 2024 May; 38(5):969-980. PubMed ID: 38519798
[TBL] [Abstract] [Full Text] [Related]
2. Enhancer-activated ret confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia.
Frett B; Stephens KE; Koss B; Melnyk S; Farrar J; Saha D; Roy Choudhury S
Cancer Sci; 2024 Mar; 115(3):963-973. PubMed ID: 38226414
[TBL] [Abstract] [Full Text] [Related]
3. JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers.
Lu X; Yu R; Li Z; Yang M; Dai J; Liu M
Cancer Lett; 2024 Feb; 582():216517. PubMed ID: 38101609
[TBL] [Abstract] [Full Text] [Related]
4. Identification of a Selective FLT3 Inhibitor with Low Activity against VEGFR, FGFR, PDGFR, c-KIT, and ret Anti-Targets.
Akwata D; Kempen AL; Dayal N; Brauer NR; Sintim HO
ChemMedChem; 2024 Jan; 19(1):e202300442. PubMed ID: 37971283
[TBL] [Abstract] [Full Text] [Related]
5. Ponatinib: An update on its drug targets, therapeutic potential and safety.
Gao Y; Ding Y; Tai XR; Zhang C; Wang D
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188949. PubMed ID: 37399979
[TBL] [Abstract] [Full Text] [Related]
6. PLM-101 is a novel and potent FLT3/ret inhibitor with less adverse effects in the treatment of acute myeloid leukemia.
Choi YJ; Park J; Choi H; Oh SJ; Park JH; Park M; Kim JW; Kim YG; Kim YC; Kim MJ; Kang KW
Biomed Pharmacother; 2023 Sep; 165():115066. PubMed ID: 37392657
[TBL] [Abstract] [Full Text] [Related]
7. Identification of crucial genes involved in thyroid cancer development.
Kalarani IB; Sivamani G; Veerabathiran R
J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
[TBL] [Abstract] [Full Text] [Related]
8. SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing.
Liu W; Lu X; Zhao ZH; Su R; Li QL; Xue Y; Gao Z; Sun SS; Lei WL; Li L; An G; Liu H; Han Z; Ouyang YC; Hou Y; Wang ZB; Sun QY; Liu J
Elife; 2022 Nov; 11():. PubMed ID: 36355419
[TBL] [Abstract] [Full Text] [Related]
9. Dual inhibition of BCL2L1 and MCL1 is highly effective against ret fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells.
Hirai S; Idogawa M; Sumi T; Yamaguchi M; Niki T; Sakuma Y
Biochem Biophys Res Commun; 2022 Nov; 630():24-29. PubMed ID: 36126466
[TBL] [Abstract] [Full Text] [Related]
10. Novel Germline
Provenzano A; Chetta M; De Filpo G; Cantini G; La Barbera A; Nesi G; Santi R; Martinelli S; Rapizzi E; Luconi M; Maggi M; Mannelli M; Ercolino T; Canu L
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013579
[TBL] [Abstract] [Full Text] [Related]
11. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.
Spohr C; Poggio T; Andrieux G; Schönberger K; Cabezas-Wallscheid N; Boerries M; Halbach S; Illert AL; Brummer T
Leukemia; 2022 Apr; 36(4):970-982. PubMed ID: 34903841
[TBL] [Abstract] [Full Text] [Related]
12. Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation.
Fu YH; Ou DL; Yang YR; Su KW; Chen CY; Tien HF; Lai ZS; Shen CJ; Chien HF; Lin LI
Cancer Gene Ther; 2022 Jun; 29(6):784-792. PubMed ID: 34117374
[TBL] [Abstract] [Full Text] [Related]
13. [Impact of hyperleucocytosis on erythrocytic parameters of cell blood count: management by Sysmex XN-10 ret analyzer].
Schillinger F
Ann Biol Clin (Paris); 2021 Apr; 79(2):181-189. PubMed ID: 33985936
[TBL] [Abstract] [Full Text] [Related]
14. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
[TBL] [Abstract] [Full Text] [Related]
15. Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid leukemia: A PETHEMA Study.
Rodríguez-Arbolí E; Martínez-Cuadrón D; Rodríguez-Veiga R; Carrillo-Cruz E; Gil-Cortés C; Serrano-López J; Bernal Del Castillo T; Martínez-Sánchez MDP; Rodríguez-Medina C; Vidriales B; Bergua JM; Benavente C; García-Boyero R; Herrera-Puente P; Algarra L; Sayas-Lloris MJ; Fernández R; Labrador J; Lavilla-Rubira E; Barrios-García M; Tormo M; Serrano-Maestro A; Sossa-Melo CL; García-Belmonte D; Vives S; Rodríguez-Gutiérrez JI; Albo-López C; Garrastazul-Sánchez MP; Colorado-Araujo M; Mariz J; Sanz MÁ; Pérez-Simón JA; Montesinos P;
Transplant Cell Ther; 2021 Apr; 27(4):311.e1-311.e10. PubMed ID: 33836871
[TBL] [Abstract] [Full Text] [Related]
16. ret Gene Fusions in Malignancies of the Thyroid and Other Tissues.
Santoro M; Moccia M; Federico G; Carlomagno F
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32326537
[TBL] [Abstract] [Full Text] [Related]
17. Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.
He BL; Yang N; Man CH; Ng NK; Cher CY; Leung HC; Kan LL; Cheng BY; Lam SS; Wang ML; Zhang CX; Kwok H; Cheng G; Sharma R; Ma AC; So CW; Kwong YL; Leung AY
EMBO Mol Med; 2020 Apr; 12(4):e10895. PubMed ID: 32134197
[TBL] [Abstract] [Full Text] [Related]
18. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Durham BH; Lopez Rodrigo E; Picarsic J; Abramson D; Rotemberg V; De Munck S; Pannecoucke E; Lu SX; Pastore A; Yoshimi A; Mandelker D; Ceyhan-Birsoy O; Ulaner GA; Walsh M; Yabe M; Petrova-Drus K; Arcila ME; Ladanyi M; Solit DB; Berger MF; Hyman DM; Lacouture ME; Erickson C; Saganty R; Ki M; Dunkel IJ; Santa-María López V; Mora J; Haroche J; Emile JF; Decaux O; Geissmann F; Savvides SN; Drilon A; Diamond EL; Abdel-Wahab O
Nat Med; 2019 Dec; 25(12):1839-1842. PubMed ID: 31768065
[TBL] [Abstract] [Full Text] [Related]
19. Can Less Intensive Chemotherapy and an Autotransplant Cure Adult T-Cell Acute Lymphoblastic leukemia?
Parovichnikova E; Troitskaya V; Sokolov A; Gavrilina O; Akhmerzaeva Z; Kuzmina L; Kliasova G; Chabaeva J; Kulikov S; Bondarenko S; Baranova O; Samoilova O; Kaplanov K; Minaeva N; Savchenko V;
Acta Haematol; 2020; 143(2):131-139. PubMed ID: 31597157
[TBL] [Abstract] [Full Text] [Related]
20. Targeting Small Molecule Tyrosine Kinases by Polyphenols: New Move Towards Anti-tumor Drug Discovery.
Sakle NS; More SA; Dhawale SA; Mokale SN
Curr Drug Discov Technol; 2020; 17(5):585-615. PubMed ID: 31393251
[TBL] [Abstract] [Full Text] [Related]
[Next]
